Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice-The PADIS-PE Trial.

Raj L, Robin P, Le Mao R, Presles E, Tromeur C, Sanchez O, Pernod G, Bertoletti L, Jego P, Leven F, Lemarié CA, Martin A, Planquette B, Le Roux PY, Salaun PY, Nonent M, Girard P, Lacut K, Melac S, Mismetti P, Laporte S, Meyer G, Leroyer C, Couturaud F; PADIS-PE Investigators.

Thromb Haemost. 2019 Jun 23. doi: 10.1055/s-0039-1692424. [Epub ahead of print]

PMID:
31230343
2.

Could the YEARS algorithm be used to exclude pulmonary embolism during pregnancy? Data from the CT-PE-pregnancy study.

Langlois E, Cusson-Dufour C, Moumneh T, Elias A, Meyer G, Lacut K, Schmidt J, Le Gall C, Chauleur C, Glauser F, Robert-Ebadi H, Righini M, Le Gal G.

J Thromb Haemost. 2019 May 20. doi: 10.1111/jth.14483. [Epub ahead of print]

PMID:
31108013
3.

Patent Foramen Ovale and Ischemic Stroke in Patients With Pulmonary Embolism: A Prospective Cohort Study.

Le Moigne E, Timsit S, Ben Salem D, Didier R, Jobic Y, Paleiron N, Le Mao R, Joseph T, Hoffmann C, Dion A, Rousset J, Le Gal G, Lacut K, Leroyer C, Mottier D, Couturaud F.

Ann Intern Med. 2019 May 7. doi: 10.7326/M18-3485. [Epub ahead of print]

PMID:
31060047
4.

[Direct oral anticoagulants].

Le Mao R, Tromeur C, Fofana A, Leroyer C, Lacut K.

Rev Prat. 2018 May;68(5):475-482. French. No abstract available.

PMID:
30869409
5.

Incidence of Cancer after a Second Unprovoked Venous Thromboembolic Event.

Rézig S, Mao RL, Couturaud F, Lacut K, Delluc A.

Thromb Haemost. 2019 Mar;119(3):490-495. doi: 10.1055/s-0039-1677745. Epub 2019 Jan 27.

PMID:
30685873
6.

Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial.

Couturaud F, Pernod G, Presles E, Duhamel E, Jego P, Provost K, Pan-Petesch B, Sollier CBD, Tromeur C, Hoffmann C, Bressollette L, Lorillon P, Girard P, Le Moigne E, Le Hir A, Guégan M, Laporte S, Mismetti P, Lacut K, Bosson JL, Bertoletti L, Sanchez O, Meyer G, Leroyer C, Mottier D; “PADIS-DVT” investigators.

Haematologica. 2019 Jul;104(7):1493-1501. doi: 10.3324/haematol.2018.210971. Epub 2019 Jan 3.

7.

Incidence of upper-extremity deep vein thrombosis in western France: a community-based study.

Delluc A, Le Mao R, Tromeur C, Chambry N, Rault-Nagel H, Bressollette L, Mottier D, Couturaud F, Lacut K.

Haematologica. 2019 Jan;104(1):e29-e31. doi: 10.3324/haematol.2018.194951. Epub 2018 Aug 3. No abstract available.

8.

[Pre-eclampsia prevention in 2018 in general population and in lupic women: At the dawn of a personalized medicine?]

de Moreuil C, Fauchais AL, Merviel P, Tremouilhac C, Le Moigne E, Pasquier E, Pan-Petesch B, Lacut K.

Rev Med Interne. 2018 Dec;39(12):935-941. doi: 10.1016/j.revmed.2018.06.001. Epub 2018 Jun 20. Review. French.

PMID:
29933972
9.

Statin exposure and thrombosis risk in patients with myeloproliferative neoplasms.

Delluc A, Lacut K, Pan-Petesch B, Galinat H, Lippert E, Ianotto JC.

Thromb Res. 2018 Jul;167:57-59. doi: 10.1016/j.thromres.2018.05.014. Epub 2018 May 16. No abstract available.

PMID:
29787944
10.

Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.

Heraudeau A, Delluc A, Le Henaff M, Lacut K, Leroyer C, Desrues B, Couturaud F, Tromeur C.

PLoS One. 2018 May 18;13(5):e0194973. doi: 10.1371/journal.pone.0194973. eCollection 2018.

11.

Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study.

Mollard LM, Le Mao R, Tromeur C, Le Moigne E, Gouillou M, Pan-Petesch B, Delluc A, Couturaud F, Lacut K.

Eur J Intern Med. 2018 Jun;52:22-27. doi: 10.1016/j.ejim.2018.02.030. Epub 2018 Mar 13.

PMID:
29548526
12.

Real-world incidence of cancer following a first unprovoked venous thrombosis: Results from the EPIGETBO study.

Delluc A, Ianotto JC, Tromeur C, De Moreuil C, Couturaud F, Lacut K, Le Moigne E, Louis P, Thereaux J, Metges JP, Mottier D.

Thromb Res. 2018 Apr;164:79-84. doi: 10.1016/j.thromres.2018.02.151. Epub 2018 Mar 2.

PMID:
29522910
13.

Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial.

Tromeur C, Sanchez O, Presles E, Pernod G, Bertoletti L, Jego P, Duhamel E, Provost K, Parent F, Robin P, Deloire L, Leven F, Mingant F, Bressollette L, Le Roux PY, Salaun PY, Nonent M, Pan-Petesch B, Planquette B, Girard P, Lacut K, Melac S, Mismetti P, Laporte S, Meyer G, Mottier D, Leroyer C, Couturaud F; PADIS-PE Investigators18.

Eur Respir J. 2018 Jan 4;51(1). pii: 1701202. doi: 10.1183/13993003.01202-2017. Print 2018 Jan.

14.

Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study).

Le Calloch R, Lacut K, Le Gall-Ianotto C, Nowak E, Abiven M, Tempescul A, Dalbies F, Eveillard JR, Ugo V, Giraudier S, Guillerm G, Lippert E, Berthou C, Ianotto JC.

Haematologica. 2018 Apr;103(4):607-613. doi: 10.3324/haematol.2017.180448. Epub 2017 Dec 15.

15.

Association between statin exposure and venous thromboembolism risk in cancer patients. Data from the EDITH case-control study.

De Moreuil C, Le Mao R, Tromeur C, Couturaud F, Lacut K, Delluc A.

Eur J Intern Med. 2017 Dec;46:e42-e44. doi: 10.1016/j.ejim.2017.10.008. Epub 2017 Oct 16. No abstract available.

PMID:
29046258
16.

Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study.

Le Mao R, Tromeur C, Bazire A, Gouillou M, Guegan M, Lacut K, Delluc A, Mottier D, Leroyer C, Couturaud F.

Eur Respir J. 2017 Jul 27;50(1). pii: 1700094. doi: 10.1183/13993003.00094-2017. Print 2017 Jul.

17.

Association between hospitalization for acute medical illness and VTE risk: A lower efficacy of thromboprophylaxis in elderly patients? Results from the EDITH case-control study.

Hemon F, Fouchard F, Tromeur C, Lacut K, Le Gal G, Mottier D, Couturaud F, Delluc A.

Eur J Intern Med. 2017 Oct;44:39-43. doi: 10.1016/j.ejim.2017.05.029. Epub 2017 Jun 22.

PMID:
28647342
18.

Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism.

Robin P, Le Roux PY, Lacut K, Planquette B, Prévot-Bitot N, Lavigne C, Pastre J, Merah A, Le Gal G, Salaun PY.

PLoS One. 2017 Jun 1;12(6):e0178849. doi: 10.1371/journal.pone.0178849. eCollection 2017.

19.

Thrombin Generation Measurements in Patients Scheduled for Laparoscopic Bariatric Surgery.

Thereaux J, Mingant F, Roche C, Galinat H, Couturaud F, Lacut K.

Obes Surg. 2017 Aug;27(8):2015-2021. doi: 10.1007/s11695-017-2545-5.

PMID:
28064371
20.

Reduction of coagulability state one year after bariatric surgery.

Thereaux J, Mingant F, Roche C, Galinat H, Couturaud F, Lacut K.

Surg Obes Relat Dis. 2017 Feb;13(2):327-333. doi: 10.1016/j.soard.2016.09.030. Epub 2016 Oct 1.

PMID:
27894747
21.

Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France.

Delluc A, Tromeur C, Le Ven F, Gouillou M, Paleiron N, Bressollette L, Nonent M, Salaun PY, Lacut K, Leroyer C, Le Gal G, Couturaud F, Mottier D; EPIGETBO study group.

Thromb Haemost. 2016 Oct 28;116(5):967-974. Epub 2016 Jul 28.

PMID:
27465905
22.

External validation of the modified Ottawa score for risk stratification of recurrent cancer-associated thrombosis.

Astruc N, Ianotto JC, Metges JP, Lacut K, Delluc A.

Eur J Intern Med. 2016 Dec;36:e11-e12. doi: 10.1016/j.ejim.2016.08.001. Epub 2016 Aug 31. No abstract available.

PMID:
27592403
23.

Clinical characteristics of aquagenic pruritus in patients with myeloproliferative neoplasms.

Le Gall-Ianotto C, Brenaut E, Gouillou M, Lacut K, Nowak E, Tempescul A, Berthou C, Ugo V, Carré JL, Misery L, Ianotto JC.

Br J Dermatol. 2017 Jan;176(1):255-258. doi: 10.1111/bjd.14809. Epub 2016 Dec 22. No abstract available.

PMID:
27291777
24.

Joint Model of Iron and Hepcidin During the Menstrual Cycle in Healthy Women.

Angeli A, Lainé F, Lavenu A, Ropert M, Lacut K, Gissot V, Sacher-Huvelin S, Jezequel C, Moignet A, Laviolle B, Comets E.

AAPS J. 2016 Mar;18(2):490-504. doi: 10.1208/s12248-016-9875-4. Epub 2016 Feb 2.

25.

Variations of hepcidin and iron-status parameters during the menstrual cycle in healthy women.

Lainé F, Angeli A, Ropert M, Jezequel C, Bardou-Jacquet E, Deugnier Y, Gissot V, Lacut K, Sacher-Huvelin S, Lavenu A, Laviolle B, Comets E.

Br J Haematol. 2016 Dec;175(5):980-982. doi: 10.1111/bjh.13906. Epub 2015 Dec 21. No abstract available.

PMID:
26687536
26.

Serum levels of 25(OH)D are not associated with venous thromboembolism in the elderly population. A case-control study.

Andro M, Delluc A, Moineau MP, Tromeur C, Gouillou M, Lacut K, Carré JL, Gentric A, Le Gal G.

Thromb Haemost. 2016 Jan;115(1):169-75. doi: 10.1160/TH15-02-0148. Epub 2015 Nov 5.

PMID:
26538494
27.

Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study.

Le Moigne E, Tromeur C, Delluc A, Gouillou M, Alavi Z, Lacut K, Mottier D, Le Gal G.

Haematologica. 2016 Jan;101(1):e12-4. doi: 10.3324/haematol.2015.134882. Epub 2015 Oct 9. No abstract available.

28.

Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.

Couturaud F, Sanchez O, Pernod G, Mismetti P, Jego P, Duhamel E, Provost K, dit Sollier CB, Presles E, Castellant P, Parent F, Salaun PY, Bressollette L, Nonent M, Lorillon P, Girard P, Lacut K, Guégan M, Bosson JL, Laporte S, Leroyer C, Décousus H, Meyer G, Mottier D; PADIS-PE Investigators.

JAMA. 2015 Jul 7;314(1):31-40. doi: 10.1001/jama.2015.7046.

PMID:
26151264
29.

Prevalence of antiphospholipid antibodies in psychiatric patients users and non-users of antipsychotics.

Delluc A, Rousseau A, Le Galudec M, Canceil O, Woodhams B, Etienne S, Walter M, Mottier D, Van Dreden P, Lacut K.

Br J Haematol. 2014 Jan;164(2):272-9. doi: 10.1111/bjh.12627. Epub 2013 Nov 5.

PMID:
24383845
30.

A model predicting fluindione dose requirement in elderly inpatients including genotypes, body weight, and amiodarone.

Moreau C, Pautas E, Duverlie C, Berndt C, Andro M, Mahé I, Emmerich J, Lacut K, Le Gal G, Peyron I, Gouin-Thibault I, Golmard JL, Loriot MA, Siguret V.

Thromb Haemost. 2014 Apr 1;111(4):705-12. doi: 10.1160/TH13-07-0555. Epub 2013 Dec 12.

PMID:
24337438
31.

Body mass index, a major confounder to insulin resistance association with unprovoked venous thromboembolism. Results from the EDITH case-control study.

Delluc A, De Moreuil C, Kerspern H, Le Moigne E, Mottier D, Tromeur C, Carre JL, Le Gal G, Lacut K.

Thromb Haemost. 2013 Sep;110(3):593-7. doi: 10.1160/TH13-01-0048. Epub 2013 Jun 27.

PMID:
23803721
32.

Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.

Le Moigne E, Delluc A, Tromeur C, Nowak E, Mottier D, Lacut K, Le Gal G.

Thromb Res. 2013 Jul;132(1):51-5. doi: 10.1016/j.thromres.2013.05.028. Epub 2013 Jun 18.

PMID:
23786893
33.

Intermittent pneumatic compression to prevent venous thromboembolism in patients with high risk of bleeding hospitalized in intensive care units: the CIREA1 randomized trial.

Vignon P, Dequin PF, Renault A, Mathonnet A, Paleiron N, Imbert A, Chatellier D, Gissot V, Lhéritier G, Aboyans V, Prat G, Garot D, Boulain T, Diehl JL, Bressollette L, Delluc A, Lacut K; Clinical Research in Intensive Care and Sepsis Group (CRICS Group).

Intensive Care Med. 2013 May;39(5):872-80. doi: 10.1007/s00134-013-2814-2. Epub 2013 Jan 31.

PMID:
23370827
34.

[Aspirin for secondary prevention of venous thromboembolism. WARFASA: far from being conclusive].

Delluc A, Lacut K, Mottier D.

Rev Med Interne. 2013 Feb;34(2):69-72. doi: 10.1016/j.revmed.2012.10.363. Epub 2012 Nov 13. Review. French. No abstract available.

PMID:
23154111
35.

Incidence of venous thromboembolism in psychiatric units.

Delluc A, Montavon S, Canceil O, Carpentier M, Nowak E, Mercier B, Bressollette L, Etienne S, Walter M, Mottier D, Lacut K.

Thromb Res. 2012 Dec;130(6):e283-8. doi: 10.1016/j.thromres.2012.10.002. Epub 2012 Oct 23.

PMID:
23092750
36.

Lipid lowering drugs and the risk of recurrent venous thromboembolism.

Delluc A, Tromeur C, Le Moigne E, Nowak E, Mottier D, Le Gal G, Lacut K.

Thromb Res. 2012 Dec;130(6):859-63. doi: 10.1016/j.thromres.2012.08.296. Epub 2012 Aug 30.

PMID:
22939687
37.

Antipsychotics: a real or confounding risk factor for venous thromboembolism?

Chapelle C, Quenet S, Delavenne X, Lacut K, Mismetti P, Laporte S, Beyens MN.

Pharmacopsychiatry. 2013 Jan;46(1):36-7. doi: 10.1055/s-0032-1316347. Epub 2012 Jul 20.

PMID:
22821386
38.

[Mechanical prophylaxis of venous thromboembolism].

Lacut K.

Rev Prat. 2011 Nov;61(9):1232-6. French.

PMID:
22308805
39.

Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism.

Delluc A, Malécot JM, Kerspern H, Nowak E, Carre JL, Mottier D, Le Gal G, Lacut K.

Atherosclerosis. 2012 Jan;220(1):184-8. doi: 10.1016/j.atherosclerosis.2011.10.007. Epub 2011 Oct 14.

PMID:
22035572
40.

Impact of genetic factors (VKORC1, CYP2C9, CYP4F2 and EPHX1) on the anticoagulation response to fluindione.

Lacut K, Ayme-Dietrich E, Gourhant L, Poulhazan E, Andro M, Becquemont L, Mottier D, Le Gal G, Verstuyft C.

Br J Clin Pharmacol. 2012 Mar;73(3):428-36. doi: 10.1111/j.1365-2125.2011.04095.x.

41.

Site of venous thromboembolism and prothrombotic mutations according to body mass index. Results from the EDITH study.

Delluc A, Le Moigne E, Tromeur C, Noel-Savina E, Couturaud F, Mottier D, Le Gal G, Lacut K.

Br J Haematol. 2011 Aug;154(4):486-91. doi: 10.1111/j.1365-2141.2011.08592.x. Epub 2011 Jun 14.

PMID:
21671893
42.

Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor.

Delluc A, Rousseau A, Delluc C, Le Moigne E, Le Gal G, Mottier D, Van Dreden P, Lacut K.

Blood Coagul Fibrinolysis. 2011 Jun;22(4):295-300. doi: 10.1097/MBC.0b013e32834512f4.

PMID:
21372691
43.

Noninvasive diagnosis of pulmonary embolism.

Salaun PY, Couturaud F, Le Duc-Pennec A, Lacut K, Le Roux PY, Guillo P, Pennec PY, Cornily JC, Leroyer C, Le Gal G.

Chest. 2011 Jun;139(6):1294-1298. doi: 10.1378/chest.10-1209. Epub 2010 Aug 19.

PMID:
20724733
44.

Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE.

Rodger MA, Le Gal G, Carrier M, Betancourt MT, Kahn SR, Wells PS, Anderson DA, Lacut K, Chagnon I, Solymoss S, Crowther M, Perrier A, White R, Vickars L, Ramsay T, Kovacs MJ.

Thromb Res. 2010 Sep;126(3):222-6. doi: 10.1016/j.thromres.2010.06.007. Epub 2010 Jun 26.

PMID:
20580413
45.

Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.

Le Gal G, Kovacs MJ, Carrier M, Do K, Kahn SR, Wells PS, Anderson DA, Chagnon I, Solymoss S, Crowther M, Righini M, Lacut K, White RH, Vickars L, Rodger M.

Thromb Haemost. 2010 Sep;104(3):498-503. doi: 10.1160/TH09-10-0685. Epub 2010 Jun 10.

PMID:
20539910
46.

Association of common genetic variations and idiopathic venous thromboembolism. Results from EDITh, a hospital-based case-control study.

Delluc A, Gourhant L, Lacut K, Mercier B, Audrezet MP, Nowak E, Oger E, Leroyer C, Mottier D, Le Gal G, Couturaud F.

Thromb Haemost. 2010 Jun;103(6):1161-9. doi: 10.1160/TH09-07-0430. Epub 2010 Mar 29.

PMID:
20352152
47.

Effect of two oral doses of 17beta-estradiol associated with dydrogesterone on thrombin generation in healthy menopausal women: a randomized double-blind placebo-controlled study.

Rousseau A, Robert A, Gerotziafas G, Torchin D, Zannad F, Lacut K, Libersa C, Dasque E, Démolis JL, Elalamy I, Simon T.

Fundam Clin Pharmacol. 2010 Apr;24(2):239-45. doi: 10.1111/j.1472-8206.2009.00747.x. Epub 2009 Aug 30.

PMID:
19719551
48.

Antihypertensive drugs and risk of venous thromboembolism: results from the EDITH case-control study.

Belattar FZ, Delluc A, Le Gal G, Leroyer C, Mottier D, Oger E, Lacut K.

Fundam Clin Pharmacol. 2010 Apr;24(2):255-9. doi: 10.1111/j.1472-8206.2009.00752.x. Epub 2009 Aug 17.

PMID:
19686532
49.

Association between antipsychotic drugs, antidepressant drugs, and venous thromboembolism.

Lacut K.

Clin Adv Hematol Oncol. 2008 Dec;6(12):887-90. No abstract available.

PMID:
19209139
50.

Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case-control study.

Delluc A, Mottier D, Le Gal G, Oger E, Lacut K.

J Thromb Haemost. 2009 Apr;7(4):728-9. doi: 10.1111/j.1538-7836.2009.03280.x. Epub 2009 Jan 13. No abstract available.

Supplemental Content

Support Center